106,613 Shares in Aspen Aerogels, Inc. (NYSE:ASPN) Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 106,613 shares of the construction company’s stock, valued at approximately $681,000. Janney Montgomery Scott LLC owned about 0.13% of Aspen Aerogels as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Millennium Management LLC increased its position in shares of Aspen Aerogels by 4,757.8% during the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock valued at $19,270,000 after purchasing an additional 1,588,632 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Aspen Aerogels in the fourth quarter worth approximately $13,122,000. Alyeska Investment Group L.P. bought a new position in Aspen Aerogels during the fourth quarter valued at approximately $9,504,000. Dendur Capital LP purchased a new position in shares of Aspen Aerogels during the fourth quarter worth approximately $9,207,000. Finally, Renaissance Technologies LLC raised its stake in shares of Aspen Aerogels by 472.4% during the fourth quarter. Renaissance Technologies LLC now owns 766,400 shares of the construction company’s stock worth $9,105,000 after acquiring an additional 632,500 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Stock Performance

Aspen Aerogels stock opened at $6.11 on Wednesday. The company has a current ratio of 4.22, a quick ratio of 3.53 and a debt-to-equity ratio of 0.40. The firm has a market cap of $501.69 million, a P/E ratio of -1.75 and a beta of 2.66. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $33.15. The firm has a 50-day moving average of $5.88 and a 200-day moving average of $8.08.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. Aspen Aerogels had a positive return on equity of 6.69% and a negative net margin of 65.47%. The business had revenue of $78.72 million during the quarter, compared to analysts’ expectations of $82.75 million. During the same quarter last year, the business posted ($0.02) EPS. The business’s revenue was down 16.7% on a year-over-year basis. Sell-side analysts expect that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Oppenheimer cut shares of Aspen Aerogels from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 8th. TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. Finally, Barclays reiterated an “equal weight” rating and issued a $7.00 price objective (down previously from $13.00) on shares of Aspen Aerogels in a report on Thursday, May 29th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $18.44.

Read Our Latest Stock Report on ASPN

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young purchased 20,000 shares of Aspen Aerogels stock in a transaction that occurred on Monday, May 12th. The shares were bought at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the completion of the transaction, the chief executive officer directly owned 550,856 shares of the company’s stock, valued at $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 3.40% of the company’s stock.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

See Also

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.